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Abstract 
Background:  Extensive debate surrounds the practice of continuous sedation until death to 
control refractory symptoms in terminal cancer care. We examined reported practice of UK, 
Belgian and Dutch physicians and nurses.   
Methods: Qualitative case studies using interviews.  
Setting:  Hospitals, the domestic home, and hospices or palliative care units.  
Participants: 57 Physicians and 73 nurses involved in the care of 84 cancer patients.   
Results:  UK respondents reported a continuum of practice from the provision of low doses 
of sedatives to control terminal restlessness to rarely encountered deep sedation. In contrast, 
Belgian respondents predominantly described the use of deep sedation, emphasizing the 
importance of responding to the patient’s request.  Dutch respondents emphasized making an 
official medical decision informed by the patient’s wish and establishing that a refractory 
symptom was present.  Respondents employed rationales that showed different stances 
towards four key issues: the preservation of consciousness,  concerns about the potential 
hastening of death, whether they perceived  continuous sedation until death as an ‘alternative’ 
to euthanasia, and whether they sought to follow guidelines or frameworks for practice.  
Conclusion:   This qualitative analysis suggests that there is systematic variation in end-of-
life care sedation practice and its conceptualization in the UK, Belgium and the Netherlands.   
Key words: refractory symptoms; continuous sedation until death; qualitative research; 
palliative care; palliative sedation 
 
 
 
What is already known about this topic? 
• Extensive clinical and ethical debate surrounds the practice of sedation for symptom 
palliation in end of life care, but is rarely informed by experiential accounts from 
clinicians who care for dying people. 
• Existing research, mainly survey based, shows that clinical practice with sedation in 
end of life care varies by country in spite of clear guidelines; the reasons for this are 
not understood.  
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What does this paper add? 
• Continuous sedation at the end of life is practised and perceived differently by 
physicians and nurses in the UK, the Netherlands and Belgium.  
• Differences in practice can be explained by the different values and concerns that UK, 
Belgian and Dutch clinicians have with regard to  consciousness during dying, 
hastening death, continuous sedation as an ‘alternative’ to euthanasia, and using 
guidelines for practice.  
Implications for practice, theory or policy  
• Our findings point to the need for greater understanding of different cultural and 
ethical perspectives on appropriate courses of action for the relief of suffering in the 
variety of challenging situations that clinicians are likely to face at the bedside.  
• Ethical dilemmas associated with sedation in end of life care can be usefully 
illuminated by carefully designed empirical studies enabling international 
comparisons.  
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Introduction 
Extensive debate surrounds the practice of palliative sedation 1, which entails the deliberate 
lowering of consciousness of a patient. Palliative sedation can be given in two ways: a) short 
term or intermittent sedation, or b) continuous sedation until death2. Guidelines or 
frameworks for European practice recommend that the use of continuous sedation until death 
for refractory symptoms giving rise to unbearable suffering should occur only when the 
patient’s disease is irreversible and advanced and that there should be no primary intent to 
hasten death 2-4. However empirical studies  suggest that the practice varies across a number 
of dimensions including:  prognosis, whether suffering is perceived as physical or existential 
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, types of drugs used 6, depth 7 and whether the patient has decisional capacity or has 
requested assisted dying 8.  Physicians’ religious or ethical perspectives are associated with 
different practices 9-12.   Existing evidence also suggests differences by country. A 
comparative secondary analysis of questionnaires sent to physicians in Belgium, the 
Netherlands and the UK 13 found that ‘‘country’’ predicted the probability of reporting use of 
‘continuous deep sedation’, even when correcting for other variables.  A qualitative study in 
the US and the Netherlands showed that justifications for sedation differed.14 Further, a small 
qualitative study15 found that Dutch and Belgian interviewees positioned continuous sedation 
until death as an ‘alternative’ to euthanasia , while UK interviewees placed  emphasis on the 
medical management of symptoms. In 2005 the Royal Dutch Medical Association published 
a guideline16. A comparable guideline was published in 2012 in Flanders, the Dutch-speaking 
region of Belgium 17. No national guideline exists in the UK.   
 
In this paper, we report results from the UNBIASED study (UK Netherlands Belgium 
International Sedation Study) 18 to compare how physicians and nurses from these countries 
describe their practice and what rationales they use.  
 
Participants and Methods 
Details of the methods employed are available elsewhere 18; we provide a summary here. The 
study was approved by research ethics committees as follows:  
UK: Leicestershire, Northampton and Rutland Research Ethics Committee 1, 10/H0406/57 
Belgium:  Ghent University Hospital Ethics Committee,  B670201010174.  
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Netherlands: Erasmus MC Medical Ethical Research Committee, NL33327.078.10, v03.   
Each participant gave written informed consent before taking part. We followed the 
Consolidated criteria for reporting qualitative research (COREQ) guidelines in reporting this 
study19.  
Data collection took place between January 2011 and May 2012.  
 
Study design 
A qualitative case study design enabled exploration of a complex phenomenon from a variety 
of perspectives 20.  Each case comprised the physician, nurse and bereaved relative of an 
adult cancer patient who had received continuous sedation prior to death.  
 
Settings 
To enable maximum variation in the cases studied21, we conducted the study in hospitals, the 
domestic home, and hospices (UK and the Netherlands) or palliative care units  attached to 
hospitals (Belgium).  
 
Participants and inclusion criteria for decedents 
Nurses and physicians were invited to take part if they had been closely involved in the care 
of patients aged over the age of 18 who had died of cancer and to whom sedating medications 
with the intention to decrease awareness were administered continuously to alleviate 
otherwise uncontrollable symptoms (either physical or psychological /existential), and for 
whom the sedation was in place at the time of death.  Senior clinical staff identified eligible 
decedents and then nominated the physicians and nurses most involved in their care. 
Physicians and nurses were interviewed about no more than three patients. Interviews took 
place as soon as possible after death. In most cases, this was within two months.  
 
Procedures 
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Interviews were semi-structured using an aide mémoire18. Interviews focused on 
recollections of: the care of the decedent, reasons for the use of sedation, its 
implementation and decision-making. Interviews were audio recorded, transcribed and 
translated as required.   Recruitment to interviews commenced in January 2011 and was 
complete by May 2012.  
 
Analysis 
We wrote up the interviews attached to each decedent’s case into qualitative case 
studies. To aid rigour, for selected cases this was done independently by two researchers 
from different countries 22, with cross case comparison undertaken by exchange and 
study of different cases from different countries and care settings by the international 
research team.  In addition, we undertook a thematic analysis based on Strauss and 
Corbin’s  constant comparative method 23 to aid within case analysis. We presented 
overviews of  findings to clinical audiences, including some study participants, in a 
process of respondent validation 22.  
Findings 
We studied 84 patient cases (22 UK; 35 NL; 27 BE) involving interviews with 57 physicians 
(17 UK; 22 NL; 18 BE) and 73 nurses (25 UK; 28 NL; 20 BE).  Table 1 gives characteristics 
of the interviewees, showing that the majority (73 out of 130) were palliative or hospice care 
practitioners. Table 2 provides an overview of the characteristics of the patients and their care 
setting.  Table 3 provides examples of the range of reasons described by participants for 
provision of continuous sedation until death.   
Tables 1, 2 and 3 about here 
 
UK  
The practice of continuous sedation until death as reported by UK physicians and nurses 
UK respondents described a continuum of practice, from the provision of low doses of 
sedatives commonly given to patients to control terminal agitation or restlessness (referred to 
as ‘normal end of life care with sedation’ by one hospice physician (see quote 1, below), to 
7 
 
the provision of continuous deep sedation in rare and highly memorable situations where it 
was exceptionally challenging to bring suffering under control (see quote 2, below):  
Quote 1: I think the Liverpool Care Pathway has been extremely helpful in highlighting 
that agitation at the end of life is relatively common and can be well treated and well 
managed, and the quality of end of life care that patients receive and families 
experience can be improved by recognising that as a symptom and treating it. And I 
would put that into the bracket of, of relatively normal end of life care with, with 
sedation. There are some cases – and they, they stick in your mind and you’ll probably 
get a few of them in the study – where, you know, it taxes people enormously... to make 
sure that somebody isn’t distressed or agitated at the end of life (Consultant Physician, 
hospice 2, case 4: reflecting on the care of a 79 year old woman who died from 
glioblastoma, which he said typified normal practice with sedation) 
Quote 2: So in the end we gave him some phenobarbitone and he needed three 
injections of 200 mg before he finally settled, but he died a few hours later. So we did 
settle him in the end, but it was unpleasant for everybody, and his wife had a very 
difficult time. I think she found it very hard, understandably. ..  he had very resistant 
agitation is what I‘d say. So phenobarbitone’s not something we use very frequently 
and it’s something we use so infrequently that you think, ‘Oh my goodness, how do we 
use it?’(Consultant Physician, Hospice 1, Case7: reflecting on the care of a 52 year old 
man who died of lung cancer and cerebral metastases, and suffered extreme pain and 
distress) 
 
 Often there was no intent reported for continuous sedation, once started, to continue until 
death. UK respondents, especially nurses, describing using sedatives to ensure that dying 
patients were ‘settled’ or ‘comfortable (see quote 4 and 5 below):  
Quote 4: … our aim when we set out to start a syringe driver and make the changes to 
the syringe driver, was to see if we can get her settled (Specialist Registrar, Hospice 2, 
Case 1: reflecting on the care of a 32 year woman who died of cervical cancer, with 
terminal agitation). 
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Quote 5: I don’t usually use the word ‘sedation’, I use the term ‘make him more 
comfortable and settled’ (Junior nurse, hospital case 3: reflecting on the care of an 83 
year old man who died of metastatic bowel cancer, with terminal agitation). 
 
Being ‘settled’ or ‘comfortable’ was portrayed as being ‘just rouseable’, akin to light sleep.  
Several physicians described sedation as a ‘side effect’ of managing difficult physical 
symptoms (quote 6, below):  
Quote 6: Actually what we’re aiming for is the kind of minimum amount of sedation 
needed to get symptoms under control… it may require regular medication along with 
extra doses and needing sort of quite, quite heavy doses of sedation, but, you know, the 
aim isn’t to sedate the aim is to relieve symptoms… we try very hard to give the 
medication for the symptom relief with a recognised side-effect that we’re trying to 
minimize (Consultant Physician, hospice 2, case 2: reflecting on the care of a 66 year 
old man who died from metastatic prostate cancer, with terminal agitation) 
 
An example of this was when one junior doctor said that she did not give people continuous 
sedation but instead ‘medications to relieve agitation’ ( see quote 7, below), which had 
sedative side effects:    
Quote 7: I haven’t given anybody continuous sedation;  there have been lots of patients 
who have become agitated at the end of their lives and in those cases it’s appropriate to 
give  medications to relieve that agitation and that restlessness, so we are giving drugs 
that do have sedative effects but the aim is not necessarily to sedate, the aim is to 
relieve that agitation and restlessness and make them more comfortable (Junior doctor, 
hospice 1, case 4: reflecting on the care of a 72 year old man who died of urological 
cancer, with terminal agitation) 
 
In the UK, normal practice was reported as entailing provision, usually at the nurse’s 
discretion, of low doses of ‘core’ sedative, anti-emetic and analgesic drugs to the patient in 
accordance with a prescription that had been written up by physicians in anticipation of 
symptoms which may occur (see quotes 8 and 9, below).  In the cases studied, there were no 
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reports on the provision of clinically assisted hydration once continuous sedation was started, 
except for the delivery of medication:  
Quote 8: We tend to give small doses; ‘prn’ to begin with, and then perhaps another 
one or two if that is not successful. But then we would move to a syringe driver, rather 
than going in and giving 5, 6, or 7 ‘prn’ doses a day. We can’t do that so we tend then 
to go to syringe driver, it makes it easier to manage a case (Nurse, community case 1: 
reflecting on the care of a 66 year old man who died of pancreatic cancer, with 
unresolved terminal agitation) 
 
Quote 9: I think this patient was only in [hospice] for, for less than two days – we 
always start with quite low doses; we always start in a cautious way and sometimes 
when you do that, people need another dose and then another dose and then an 
escalation in the dose in their syringe driver, because you’ve started cautiously and 
built up rather than starting with a high dose and then, and completely flattening 
somebody at the outset, and that can sometimes be difficult. I think it’s, these sorts of 
cases are ones where the patient needs regular review and the family need to know that 
that’s the intention, to review regularly and to be able to give an extra dose if necessary 
(Consultant Physician, Hospice2, case 4: reflecting on the care of a 79 year old woman 
who died from glioblastoma, which he said typified normal practice with sedation) 
  
Reported rationales for practice  
Four factors provided a rationale for the practice as reported by UK practitioners.  
Firstly, many UK respondents were anxious that the use of ‘heavy’ doses of sedative may 
hasten death or be seen to be equivalent to euthanasia (see quote 10, below). This was notably 
present among nurses, and less so among hospice consultants. Dilemmas were perceived to 
be posed by patients who requested assisted dying; hospice respondents reported that this 
sometimes occurred in patients with very high symptom burdens:  
 Quote 10: So I know our tendency is to start small because people worry about it and 
they worry that people will suddenly be sedated and people will assume that’s what’s 
killing them. … And even in hindsight thinking, ‘Would I have done it differently?’, 
10 
 
talking to my team they all said, ‘But [nurse’s name] we always start small.’ (Specialist 
palliative care nurse, hospital case 1: reflecting on difficult death of 65 year old man 
from lung cancer, with uncontrolled symptoms). 
 
Second, UK physicians and nurses sought to ensure that patients could maintain interaction 
for as long as possible, while seeking to provide enough sedation to ensure that patients 
became ‘settled’ and ‘comfortable’.  Some respondents considered it to be morally wrong to 
decrease or remove a patient’s consciousness (see quotes 11-13 below):    
Quote 11: He was needing to have quite a lot of extra doses in that last period, and 
there’s, there is a sense that you don’t want to over-sedate people... looking back at 
that… I think I might have put a bit more in the driver considering he was already on 
quite a lot of oral or, you know, peg diazepam. But I think staff have a real concern 
they don’t over-sedate people because they don’t want to be seen to be knocking them 
out. I guess when you’re looking at how much you sedate people, it’s important to be 
proportionate; it’s also important to be effective (Consultant Physician, hospice 1, case 
3: reflecting on the care of a 51 year old man who died from naso-pharyngeal cancer, 
with difficult symptoms and who requested sedation). 
 
Quote 12: …we’re probably a little bit more cautious in general practice in terms of 
how we, how we start it.  And, and that might be to the detriment of the patient at times, 
I wonder (GP, community case 3: reflecting on the care of an 87 year old woman who 
died of lung cancer, with terminal agitation). 
 
Quote 13: … we want them to be comfortable but we don’t want to totally knock them 
out and not have interaction with their family;  and the family is quite happy to see him 
comfy, settled  (Junior nurse, hospital case 3: reflecting on the care of an 83 year old 
man with metastatic colon cancer) 
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Third, commencement of the Liverpool Care Pathway was reported to be a signal to activate 
an anticipatory prescription (sometimes referred to as ‘just in case’ prescriptions) including 
the use of sedative drugs (see quote 14, below):    
Quote 14: …when we start the Liverpool Care Pathway at the end of life- the end of life 
drugs that are prescribed anyway in case all these symptoms associated with dying 
come up,-and if we feel, like the nurses feel that my patient is getting agitated or is in a 
lot of pain, we can just go ahead and give it. And they always prescribe like a range 
starting from the lower to the upper limit so we just sort of titrate and go up as, you 
know, how much your patient needs or how agitated they’re getting (Nurse, hospice 1, 
case 4).  
 
Fourth, respondents were concerned to ensure that they balanced the perspectives of patients, 
families and their colleagues when deciding how to manage a patient’s distress (see quotes 
16-19, below). This was especially noticeable in the five out of 22 cases studied where 
patients had what one respondent described as ‘resistant agitation’ (see quote 2 in table 3).   
Quote 16: How do you do something to a patient, even if it’s what we want, that the 
family are saying you mustn’t do? And the books say: competent patient, ignore the 
family, do what the competent patient wants….. I mean the books would say he was 
competent and we were all clear, the psychiatrist was clear, he wasn’t depressed, he 
was competent, he wanted to be asleep, we’d tried everything else... but how do you 
sedate someone fully when the wife is saying, ‘Don’t do it.’ I don’t know (Consultant 
Physician, Hospice1, Case 1: reflecting on the care of a 60 year old man with lung 
cancer, whose wife was unhappy about the use of sedation) 
 
Quote 17: I go and say [to the family], ‘It’s we who made the decision, and not I who 
made the decision,’ so, and that gives more strength saying it’s me as a part of the 
team.’(Specialist Registrar, Hospice 2, Case 1) 
 
Quote 18: …I would still always ring the out-of-hours GPs even though it’s [drugs are] 
written up, and discuss it and you’ll find that the out-of-hours doctors are, you know, 
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some will either come out or discuss it over the telephone with you and be happy to, to 
go on your clinical judgement. But, yeah, I think it’s got to be a team decision’. (GP, 
community case 8) 
 
Belgium  
The practice of continuous sedation until death as reported by Belgian physicians and nurses 
In Belgium, there was a variety of patterns in respondents’ accounts. The predominant pattern 
was to seek to relieve patients’ suffering by establishing deep sedation either by starting with 
low doses of sedatives and then increasing these quickly, or by the provision of high dosages 
from the outset (see quotes 1-3, below):   
Quote 1: The aim of sedation is really to get someone fully sedated. As I said, we had a 
discussion about this on a daily basis with the palliative team and then it was switching 
to barbiturates, which was something we would have done, well, if I had estimated that 
it would still have taken a few days, we would certainly have done that… In retrospect 
you could say, maybe we should have switched from Dormicum [midazalom] to other 
products a day earlier (GP, community, case 9: reflecting on the care of a 61 one year 
old man who died of retroperitoneal metastases).  
 
Quote 2: I know in the beginning, uh, the first day she wasn’t really asleep. Then I did 
get back in contact with [Palliative Home Care Nurse Association] and then the 
medication was increased ...normally speaking they enter a deep sleep fairly quickly 
they, but that actually wasn’t the case with her, although she wasn’t in pain   
I: So first it was too low and then it was increased? 
And then she was actually in a deep sleep, yes. (Nurse, community, case 4: reflecting on 
the care of a 70 year old woman who died of colon cancer). 
 
Quote 3: We used the Pentothal to deepen the sleep of the man and he died the next day 
at 21.00 o’clock …we never give fluids or nutrition ... we always stop in time, 
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preferably before we start with the sedation, but at the time of sedation. Then we 
basically stop everything, because you want to support a natural dying process, or 
initiate it as was done here. (Physician, palliative care unit, case 5: describing 
continuous deep sedation over 8 days, with an anaesthetic agent used on day 7, in the 
management of a man with colon cancer who was reported to have lost the will to live) 
 
In the few examples where it was reported that patients had lost capacity, no such attempt to 
induce deep sedation was described (see quotes 4-5, below). Instead sedation was described 
as ‘medical decision’; for example, in once case a GP described it as in ‘acute medical help’ 
for refractory dyspnoea  in his recollections of caring for a patient with lung cancer.  
Quote 4:  [We] eventually administered sedating medications and then they started at a 
dose which offered relative certainty that she would be calm. ... So in fact there we did 
not have a deep sedation; there was no request from her and there wasn’t really a 
request from the family ... it was decided to proceed to sedation, but rather in relation 
to the symptom. (Physician, palliative care unit, case 6: reflecting on the care of a 61 
year old woman who died from a glioblastoma). 
 
Quote 5: And at that moment I thought yes, this guy is too scared now to rationally 
decide for himself and I need to intervene. So I took the family outside to discuss the 
matter with them, they had been sitting with him for the past 72 hours with a scared 
look on their faces and I said ‘look I will intervene for his own good and put him to 
sleep because he is too afraid to say yes now’ ...the family agreed and was also glad 
that I had suggested it. ... So I started with the dose he needed at [the previous night]. I 
always start with a dose of one mg per hour and every hour I get the nurses to evaluate 
how it’s going and increase it, for me. When they are sleeping peacefully, then they 
freeze the dose (Oncologist, hospital oncology unit, case 12: reflecting on the care of a 
30 year old man who died of melanoma). 
   
It was reported to be usual practice to withdraw or withhold clinically assisted nutrition and/ 
or hydration as soon as continuous sedation until death started, unless a patient had made a 
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specific request to receive hydration.  Belgian nurses reported a variety of responsibilities 
with regard to their role, from the provision of advice to GPs, to carrying out physicians’ 
instructions. Belgian respondents made a variety of references to guidelines and protocols: 
some relied on experience; others reported consultation with local palliative care specialists.  
A few made reference to Dutch guidelines (see quotes 6-10, below):     
Quote 6: I don’t know if they have something like that in the department here, or if an 
actual protocol was written, but I've always - I have my own standards (Oncologist, 
hospital oncology unit, case 16)  
 
Quote 7: No, only a consultation with the palliative network (GP, community, case 1) 
 
Quote 8: We must follow the instructions of the doctor… because we always depend on 
the doctors to start the treatments. (Nurse, community, case 1) 
 
Quote 9: No. I have taken a course in palliative care, but no guidelines were ever 
mentioned (GP, community, case 2) 
 
Quote 10: I have the protocol... that is the protocol from the Netherlands …yes I also 
used these guidelines with this case. This is also in my doctor's bag -the guidelines from 
the KNMG (GP, community, case 25) 
 
Reported rationales for practice  
Three factors could be identified that provide a rationale for the practice reported by Belgian 
practitioners.  Firstly, most wanted to prevent patients coming to consciousness once sedation 
had been started and sought to sustain ‘deep sleep’ until death (see quote 11, below):  
 Quote 11: In principle it is the intention, if we sedate, that they really are well asleep 
because it is often confusing for the family that waking and sleeping, often ... the family 
no longer expects that either and often when they are awake, they are still a bit restless 
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and ... "Gosh am I still here and ...”. So I don’t find that necessary. Palliative sedation, 
I do prefer that they really are fully sedated. (Oncologist, hospital oncology unit, case 
18). 
 
Second and closely linked to the first was the perceived importance of honouring patients’ 
requests to be ‘taken out of suffering’ or to be ‘put to sleep’ (see quotes 12 and 13, below):  
Quote 12: I just clearly said ‘look I am willing to do that if you want, we've talked 
about it, we’ve discussed it with you …it is you who decides ‘(GP, community, case 4: 
reflecting on the care of a 72 year old woman who died of colon cancer).  
 
Quote 13: He then came to the unit and said 'I want to die like my wife.’ So, for him it 
was rather more of an existential question really. He wanted to die as his wife had. The 
symptoms that were bothering him or encouraged him to determine the time or moment 
was due to being bedridden, having decreased mobility and pain, the man had many 
symptoms such as chest pain caused by the illness that he had. It was also his fear of 
pain that actually helped him decide, despite the fact that it felt like we had his pain 
quite well under control. However, it was mainly the fear.  
I: So, the fear of future pain?  
The fear of future pain, especially the fear of future pain, the decay process and the 
'being done' (Physician, palliative care unit, case 5). 
 
Thirdly, a predominant emphasis (in 18 of 25 cases) was the description of continuous 
sedation until death and euthanasia as ‘alternatives’ (see quotes 14-17, table below), with 
discussions with patients and their families reported about these ‘options’.   In five cases 
physicians reported using continuous sedation until death for patients who had requested 
euthanasia but then become incompetent before they were either able to complete the formal 
process or discuss their wish with their family. In the other cases studied, continuous sedation 
was preferred by the physician over the possible ‘choice’ of euthanasia for moral reasons, or 
because patients preferred continuous sedation. Respondents accepted that continuous 
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sedation until death may hasten death where it extended over several days, although most 
said this was not their primary intention. In two cases, palliative care unit physicians 
described an explicit life shortening intent (see quote 17, below). 
Quote 14: …we have had, yes, a very open conversation once she indicated that she 
wanted to put an end to it. So we listed the various options available so ranging from – 
from actually waiting until it being spontaneous, to euthanasia - and, as an alternative, 
palliative sedation  (Oncologist, hospital oncology unit, case 20: reflecting on the care 
of a 77 year woman who died of ovarian cancer) 
 
Quote 15: I should have had the conversation about euthanasia in the beginning, 
because that was perhaps a better option [but] there is a group where perhaps 
palliative sedation is a more appropriate option because euthanasia is out of the 
question for them. So I see them as complementary   (GP, community case, 25) 
 
Quote 16: It’s not a coincidence that eventually euthanasia is being done a lot less 
frequently than sedation, because somehow… sedation is considered to be more 
naturally and it’s also more in line with what the natural process brings: more sleep 
(Physician, palliative care unit, case 26) 
 
Quote 17: With the intention of, with sedation, but not to take too long. From a…to 
have a shortening effect.   I'm honest about that.  I think that is okay, given the 
euthanasia desire, so, yes, it's, yes, I would rather say a sedation but surely in the 
direction of a slow euthanasia (Oncologist, hospital oncology unit, case 23: reflecting 
on the care of an 88 year old woman with leukaemia) 
 
The Netherlands 
The practice of continuous sedation until death as reported by Dutch physicians and nurses 
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Dutch physicians and nurses typically reported using sedation where a refractory symptom 
was present and a patient was in the last days of life. They talked about making a ‘formal’ 
medical decision following discussion with the patient and/ or their family and with 
colleagues (see quotes 1 and 2, below):  
Quote 1:… then in the course of the morning, there were talks and in the afternoon we 
officially started with sedation… Well, the doctor explained to them [family] the details 
of how it works and what it means, that there is no more contact possible with the 
patient (Hospital nurse, case 1: reflecting on the care of a woman who died of 
metastatic cancer of unknown primary) 
 
Quote 2: [The doctor] was just like: first I'm going to give that shot of Dormicum 
[midazalom], then we will immediately check the protocol and then I’ll connect the 
pump. So I think that’s how it happened….And yes that's a whole protocol of how you 
are going to start, with what dosage you give the first shot and how you proceed with 
the sedation… Yes, that all happened very officially (Hospital nurse, case 8: reflecting 
on the care of a man in his 60s, cancer type not reported). 
 
Usual practice was described as involving starting with low doses of sedative and then 
cautiously increasing the dosage until the patient was in a quiet and peaceful state (quotes 3-
5, below).  Once sedation was started, artificial hydration was usually reported to be 
withdrawn or withheld. In most cases, nurses described having responsibility for carrying out 
the doctor’s instructions, monitoring the response of the patient to the sedatives once started 
and, if required, increasing the dosages according to medical instruction.   
Quote 3: Yes, if people, if the family, or us, nurses or doctors feel that the patient is still 
a bit restless, then the dosage is increased… But thus far, from what I’ve experienced a 
large increase is rarely needed (Hospital Physician, case 1) 
Quote 4: So look, you’re trying to get the situation under control again, you try to 
create peace and it's not about injecting someone out of this world, you just want the 
situation to be calm again. For the patient, for the relatives. But you do not want too 
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much (Hospital nurse, case 4: reporting on the care of a woman (age not reported) who 
died of cerebral metastases). 
Quote 5: With the dose that we give we always try to start with the lowest dose, so we 
don’t force anything…we just start according to the guideline, low (Hospice physician: 
case 21: reflecting on the care of a 78 year old man who died of mesothelioma) 
 
Reported rationales for practice  
In the Netherlands, the presence of the national palliative sedation guideline framed most 
respondents’ reports. For example, the manner of titration of medications was described to be 
prescribed by the guideline. Terms related to key indications for continuous sedation in the 
guidelines were used frequently by the respondents, such as “refractory suffering”. However, 
several Dutch physicians reported that they found it sometimes necessary to ‘work round’ the 
guideline to meet patients’ needs, especially when suffering was perceived to be neither 
wholly physical nor refractory (see quotes 6-8, below): 
 Quote 6: ….we have a protocol for sedation, which is of course approved through the 
KNMG [Koninklijke Maatschappij ter bevordering van de Geneeskunde – Royal Dutch 
Medical Association], which is used nationwide (Hospital nurse, case 4).  
Quote 7: Yes you must do this according to the protocol. Of course you need to have 
good communication with family, doctors and nurses and be on the same wavelength 
(Hospital nurse, case 8) 
Quote 8: We definitely follow the rules when it comes to sedation. So the prognosis has 
to be less than two weeks, with refractory symptoms. And sometimes I think that we 
have to wait too long for that …So when she got the itch that we could do nothing about 
I thought hooray, we have a refractory symptom, now we can do sedation… (Hospital 
physician, Case 3: reflecting on the care of a 59 year old woman who died of renal 
cancer). 
 
Second, while some Dutch respondents talked about continuous sedation and euthanasia as 
‘alternatives’, others made a clear distinction. It was explained that contrary to euthanasia: (1) 
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sedation is a natural death, neither directly contributing to death nor hastening it (see quote 9 
below):  
Quote 9: So it's basically just nature doing her job. So in that respect it's not actively 
contributing to death. Only in the way that everything else stops completely, the intake 
of fluids... Of course that can indirectly hasten death, but it is not an active termination 
… [in] euthanasia we often indicate that it has to be a longer process and that someone 
has to indeed be completely lucid… [the options discussed were] euthanasia, sedation 
or the natural way. Well, sedation is the natural way with a lot of symptom control 
(Hospital physician, case 2: reflecting on the care of 56 year old man who died of 
sarcoma) 
(2) Sedation controls refractory symptoms when the requirements for euthanasia cannot be 
met (such as lack of capacity or too little time to consult a second physician), and (3), the use 
of sedation is primarily a medical decision (quotes 10-11, below):  
Quote 10: Yes, the psychiatrist, the ward doctor, and then yes the nurse who cared for 
her. And well yes, Mrs. X  and her husband were probably also involved in the 
decision… it is in principle a decision that the doctor in consultation with the patient... 
and then the nurse..... And the ward doctor consults [about] that with the supervisor. 
(Hospital nurse, case 3). 
Quote 11: That first discussion was the most important, it took place on [date]; at that 
time we considered the options.  Choices were made then. I am a general practitioner 
who prefers to work with palliative sedation. I do have some difficulty with euthanasia. 
I: And what did he think of this? Did you also discuss euthanasia at this time?  
R: Yes of course we discussed it.  
I: And what did he think of this? 
R: Initially, he thought that euthanasia would be a good solution. But when I explained 
the method of palliative sedation to him, he said he would like to have this too. Then the 
decision is not difficult for me to make. So finally, after a really thorough discussion we 
decided on palliative sedation. And that’s the way it goes.  I admit that my guidance 
played some part in the decision… The decision is mine, and I wish to emphasize this 
fact to people – this is another thing that goes with palliative sedation. I have said that 
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the decision is mine to make because palliative sedation cannot be administered in 
every situation (GP, case 11: reflecting on the care of man aged 78 who died of lung 
and colon cancer). 
 Some interviewees welcomed a quick death once sedation had been started and a minority 
pattern of perception was that sedation does hasten death (quotes 12 and 13, below).   
Quote 12: Yes, what you do read and hear is that people do not die sooner because of 
palliative sedation; I don’t believe any of it. That doesn’t correspond with my practical 
experience; it almost always goes incredibly fast (GP, case 12: reflecting on the care of 
a 64 year old man who died of oesophageal cancer).  
Quote 13: ...it increases the process of death …so I definitely think that it plays a role 
(GP, case 15) 
 
The third factor was the need to ensure that once sedation was commenced the patient did not 
come to awareness to avoid suffering (quotes 14 and 15, below):  
 Quote 14: Yes, deep sedation, really a dormant state, a body which is at rest and so is 
a little relaxed. And the moment that you are going to turn them, that there is no 
response (Hospital nurse, case 4: reflecting on the care of a 33 year old woman who 
died of breast cancer). 
 
Quote 15: And so of course it had to be done well, because I could not have it that she 
would still wake up or that something else would happen and that I was not there. Then 
the pump would immediately need to go up, because she had to remain comfortable 
(Hospital physician, Case 10: reflecting on the care of a 51 year old woman who died 
of lung cancer). 
 
Discussion  
This exploratory study of the use of continuous sedation until death for cancer patients has 
shown that UK respondents report a continuum of practice from the provision of low doses of 
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sedatives to control terminal restlessness to rarely used continuous deep sedation. In contrast, 
Belgian respondents predominantly describe the use of deep sedation, emphasizing the 
importance of responding to the patient’s request for relief of suffering.  Dutch respondents 
place emphasis on the making of an official medical decision informed by the patient’s wish 
where this is known and establishing that a refractory symptom was present before 
commencing sedation.   Respondents employed rationales that showed different stances and 
values towards four key issues in the three countries. The first issue involved the preservation 
of consciousness. UK respondents sought to maintain patients in a ‘settled’ but ‘just 
rouseable’ state. This gave raise to their descriptions of sedation as a ‘side effect’. In contrast, 
Belgian practitioners reported the need to ensure that patients ‘stayed asleep’, focusing on 
honoring the choice of a patient who asked for sedation.   A more mixed picture with regard 
to consciousness was observed in the Dutch accounts, although, most set a similar value on 
‘staying asleep’.  There has been comparatively little attention to the values placed on 
consciousness in previous research, although quantitative studies reveal contradictory stances 
both within physician samples and between countries9.  Our findings resonate with the results 
of a Japanese survey, which found that continuous sedation was more frequently performed 
by physicians who did not believe consciousness was necessary for a good death 24. A 
qualitative study of Dutch physicians showed that depth of sedation varied according to 
whether physicians placed emphasis on the duty to relieve suffering or the duty to observe the 
patient’s response to medication7.  Our finding that UK physicians referred to sedation as a 
‘side effect’ resonates with results from a survey of US physicians where  85% agreed that 
unconsciousness is an acceptable side effect of palliative sedation mirroring language in US 
guidelines 25.  
 
The second key difference concerned perspectives towards hastening death.  Although there 
is a body of evidence showing that where sedation is performed correctly, it does not hasten 
death26, interviewees took variable positions towards this. UK practitioners thought hastening 
death may be a possible result of the use of continuous sedation and wanted to avoid this; 
findings that are similar to those in a study of Australian palliative care specialists27. In 
contrast, some Belgian physicians accepted that continuous sedation may hasten death and in 
two cases reported a life shortening intent. In the Netherlands, most practitioners did not 
perceive that sedation hastened death and they tended to describe continuous sedation as 
enabling a ‘natural’ death 28.  
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A third difference centered on whether continuous sedation until death could be an alternative 
to euthanasia. There was little mention of euthanasia by UK respondents; clearly this will 
have been influenced by the fact that there has been no legalisation of euthanasia in the UK.  
In contrast, most Belgian respondents perceived continuous sedation until death and 
euthanasia to be ‘alternatives’ which could be chosen by patients.  This perception appeared 
less strongly in the Dutch accounts,  although Dutch clinicians sometimes reported discussing 
the ‘option’ of continuous sedation until death with patients; this was usually in situations 
where euthanasia had been talked about  at an earlier point but could not be carried out at the 
time of the appearance of refractory suffering.  While the European Association for Palliative 
Care has issued an ethical statement distinguishing between the two practices29, our data 
suggest that the perceptions of practitioners working in countries where euthanasia has been 
legalized may take a different view; this needs further attention in future research.  
 
Fourth, the degree to which reports of practice were shaped by the presence or absence of 
guidelines was notable.  Dutch respondents referred very frequently to the ’official’ 
recommendations in a national guideline which has legal ramifications, while reference to 
guidelines in the Belgian accounts was much more variable. Among UK respondents, 
especially those in non-hospice settings,  the commencement of the Liverpool Care Pathway 
was regarded as a permissive ‘signal’ for use of low doses of ‘core’ drugs including sedatives 
where the patient started to exhibit signs of agitation.  Previous Dutch research suggests that 
practice has changed  towards compliance in the Netherlands since the publication of the 
national guideline, although there remains variety in symptom directed treatment and some 
concerns about life shortening consequences of sedation 30.    Existing research in Belgium 
resonates with our findings, suggesting that Belgian physicians tend to be unfamiliar with 
existing recommendations and engage in  variety of practices when using sedation in end of 
life care including life shortening intent  that are out of step with the latter  31; 32. There is no 
rigorous research about the relationship between the Liverpool Care Pathway and sedation 
practice, although audit data exist 33.   
Strengths and limitations 
The validity of this study was increased by purposively sampling physicians and nurses from 
three different care settings who had been closely involved in the end of life care of decedents 
identified using standardized criteria.   However this study has a number of limitations.  Our 
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interview data is dependent on the subjective experience and interpretation. Although our 
retrospective design does not preclude recall bias, this was limited in most of the cases by 
minimizing the time between the patient’s death and the interview with the practitioners to 
two months.  Further validation of our findings requires study of their resonance with other 
clinicians involved in the care of dying patients.    
 
Conclusion 
Our findings point to the need for greater understanding of different cultural and ethical 
perspectives on appropriate courses of action for the relief of suffering in the variety of 
challenging situations that clinicians are likely to face at the bedside.  Recognizing that 
practice is situated in different legal contexts, values and histories associated with palliative 
and end of life care may inform what are frequently contentious discussions about practice 
and policy in sedation.   
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Table 1: Physicians’ and nurses’ characteristics 
Characteristics Physicians (N=57) Nurses (N=73) 
Country 
 
UK 
(N=17) 
BE 
(N=18) 
NL 
(N=2
2) 
UK 
(N=25) 
BE 
(N=20) 
NL 
(N=28) 
Age <40 7 5 10 9 7 12 
 40-50 6 6 3 8 7 7 
 >50 4 6 9 5 5 9 
 Not stated 0 1 0 3 1 0 
Gender        
 Male 8 9 12 0 3 2 
 Female 9 9 10 25 17 25 
Specialism        
 Primary care  5 7 10 3 6 1 
 Palliative home care team 0 2 0 4 5 8 
 Hospital  4 2 3 2 5 9 
 
Palliative care /hospice  
care 
8 7 9 16 4 10 
 Unknown 0 0 0 0 0 0 
*this includes  clinicians attached to specialist palliative teams in hospitals, palliative care units in 
hospitals (BE) and hospices (UK and NL) 
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Table 2:  Characteristics of patients   
 
Cases  (Belgium (n= 27),Netherlands (n=35), UK 
(n= 22) N=84 
Age   
 
<40 6 
 
41-60 20 
 
61-80 45 
 
>80 11 
 
Unknown 2 
Gender   
 
Male 43 
 
Female 41 
Diagnosis   
 
Adenocarcinoma, peritoneal or 
sarcoma 
5 
 
Abdominal/ stomach 3 
 
Bladder /renal 7 
 
Colo-rectal 8 
 
Brain/ glioblastoma 6 
 
Breast 5 
 
Gynaecological  4 
 
Facial maxillary/oesophageal 2 
 
Gall bladder / pancreatic  7 
30 
 
 
Leukaemia/ myelofibrosis / 
myeloma 
4 
 
Lung/ mesothelioma  16 
 
Melanoma 4 
 
Prostate 7 
 
Unknown primary 6 
Care setting   
 Home 
30 (9 UK; 11 
BE; 10 NL) 
 Hospital 
28 (4 UK; 10 
BE; 14 NL) 
 
Palliative care unit (BE) / hospice 
(UK/ NL) 
26 (9UK; 6 BE; 
11 NL) 
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Table 3:  Example of the range of reasons for using continuous sedation until death  
 
Refractory pain and / or delirium 
‘ …. at night, with the change in how he coped, his character changed completely. He became aggressive; 
he became abusive and was not a man you could reason with, and we felt as though, as a team, we were 
chucking the cupboard at him and nothing was touching this pain. And we went through  escalating doses 
of... well, the ketamine, we added in clonazepam, we added in other opiates, and we just didn’t seem to 
be getting anywhere. And this behaviour of non-coping and escalated pain then began to encroach into 
the day as well. .. And even that, with the  doses of phenobarbitone that was the case, you know, it wasn’t 
a quick, easy solution’ (UK Hospice nurse, case 7, reflecting on the care of a 52 year old man who died of 
lung cancer and cerebral metastases, with extreme pain and distress) 
‘It [sedation]  was discussed with the family and [patient] because of the pain …Because the handling was 
extremely painful (Belgian general practitioner, case 1, reflecting on the care of 57 year old woman with a 
glioblastoma multiforme and a hip fracture, who died at home and suffered extreme pain from her hip 
fracture).  
 
…she indeed became increasingly confused, painful, without the actual possibility of adequate medical 
therapy anymore’ (Netherlands, hospital physician, case 1 reflecting on the care of a woman of 54 who 
died of an unknown primary cancer, with refractory pain and generalised extreme distress) 
 
‘…there was a lot of confusion, a lot of agitation and the doctor who was looking after him sort of ran to 
the bay with the nurses and tried to calm him down. He was very aggressively agitated ‘ (UK Junior hospital 
doctor, case 3: reflecting on the care of a 83 year old man who died in hospital with bowel cancer and 
cerebral metastases). 
 
Responding to a patient’s request for relief from pain 
‘….And I discussed that, yes, that was an option for her to be put to sleep [to] make you feel comfortable 
[so] that she would not feel the pain’ (Belgian oncologist, case 17, reflecting on the care of a 76 year old 
woman with pancreatic cancer, who died in hospital).  
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Refractory nausea and vomiting 
‘…the medicines he was having to control his sickness, it wasn’t controlling it. It was, it was breaking 
through.  I’d say after  three, maybe four days, it was starting to present itself and it was pretty bad.’ (UK 
general practitioner, case 1: reflecting on the care of 80 year old man who died at home with  gallbladder 
cancer).  
 
‘… Thursday night he started vomiting blood, and he was, at that moment he was conscious and 
approachable and vomiting blood and we had to give extra [sedative] medication against the vomiting’ 
(Belgian general practitioner, case  9, reflecting on the care of a 61 year old man who died at home with 
metastastic cancer, unknown primary). 
 
Refractory dyspneoa 
‘… he had started to get a chest infection; he had a lot of secretions which, because he was missing so 
much of, like, the roof of his mouth’ (UK Hospice consultant, case 3, reflecting on the care of 51 year old 
man who died in a hospice with a naso-pharyngeal tumour ).  
 
‘…on Monday morning he was still there, but, he was very miserable so I then decided; I going to sedate 
him because it wasn’t really possible anymore.  
Int.   And how do you mean miserable?  
Miserable, he was gasping like a fish out of water even with maximum oxygen, soaked in sweat and 
stressed... Terrified, couldn’t get comfortable and could barely talk’ (Netherlands Oncologist, Case 12, 
reflecting on the care of a 31 year old man who died of malignant metastatic melanoma in hospital).  
‘…A combination of dyspnoea, pain, confusion and clear clinical deterioration for which you have 
exhausted all possibilities to fix it with medication’ (Netherlands, hospital physician, case 2, reflecting on 
the care of a 56 year old man who died with differentiated sarcoma, with lung metastases)  
Existential suffering 
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‘The man was above all, actually had a lot of existential problems. That was someone who belonged on the 
palliative unit but at that time there was no place there. That man actually asked to be left alone and [for] 
peace in the last days of his life…(Belgian oncologist, case 18, reflecting on the care of 70 year old man 
who died of gastric cancer in hospital). 
 
 
 
 
 
 
 
 
 
